🇮🇳IN
Sign In
GL

GLAXO

NSE

GlaxoSmithKline Pharmaceuticals Limited

₹2,515.10

+17.10(+0.68%)

Ownership Score

Index Membership

and the weight we carry

Mutual Fund Ownership

% of each scheme's portfolio

Insider & Deals

who traded, and how close they are to the company

Ownership & Influence

who holds it, and what else they hold

Shared directors

companies with a board member in common

GLAXO shareholding summary

As of Sep 2026, promoters held 75.00% of GlaxoSmithKline Pharmaceuticals Limited. Institutions together held 13.22%, of which foreign institutional investors held 4.75% (down 0.04 points from Jun 2026) and domestic institutions held 8.47% (up 0.66 points from Jun 2026). The public held the remaining 11.77% (down 0.65 points from Jun 2026). The company had 1,19,337 shareholders.

Promoters75.00%
FII4.75%
DII8.47%
Public11.77%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer